Structure-based Design of Flavonoid Compounds As a New Class of Small-molecule Inhibitors of the Anti-apoptotic Bcl-2 Proteins
Overview
Authors
Affiliations
Structure-based strategy was employed to design flavonoid compounds to mimic the Bim BH3 peptide as a new class of inhibitors of the anti-apoptotic Bcl-2 proteins. The most potent compound, 4 (BI-33), binds to Bcl-2 and Mcl-1 with Ki values of 17 and 18 nM, respectively. Compound 4 inhibits cell growth in the MDA-MB-231 breast cancer cell line with an IC50 value of 110 nM and effectively induces apoptosis.
Lu Y, Wu S, Yue Y, He S, Li J, Tang J ACS Med Chem Lett. 2016; 7(12):1185-1190.
PMID: 27994761 PMC: 5150665. DOI: 10.1021/acsmedchemlett.6b00302.
Cheng C, Liu Y, Balasis M, Garner T, Li J, Simmons N Mar Drugs. 2014; 12(8):4311-25.
PMID: 25076060 PMC: 4145318. DOI: 10.3390/md12084311.
Weiser P, Chang C, McDonnell D, Hanson R Bioorg Med Chem. 2013; 22(2):917-26.
PMID: 24360824 PMC: 4243926. DOI: 10.1016/j.bmc.2013.10.051.
Chen J, Zhou H, Aguilar A, Liu L, Bai L, McEachern D J Med Chem. 2012; 55(19):8502-14.
PMID: 23030453 PMC: 3495162. DOI: 10.1021/jm3010306.
Du Y, Nikolovska-Coleska Z, Qui M, Li L, Lewis I, Dingledine R Assay Drug Dev Technol. 2011; 9(4):382-93.
PMID: 21395401 PMC: 3148108. DOI: 10.1089/adt.2010.0292.